{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:44:05Z","timestamp":1786553045207,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00415-013-7124-7","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T04:40:20Z","timestamp":1381120820000},"page":"3093-3108","source":"Crossref","is-referenced-by-count":78,"title":["Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy"],"prefix":"10.1007","volume":"260","author":[{"given":"Maike F.","family":"Dohrn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Bleecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Vorgerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Y.","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ferbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hinderhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"7124_CR1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C (1952) A peculiar form of peripheral neuropathy. Brain 75:408\u2013427","journal-title":"Brain"},{"key":"7124_CR2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","volume":"119","author":"SO Sch\u00f6nland","year":"2012","unstructured":"Sch\u00f6nland SO, Hegenbart U, Bochtler T et al (2012) Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood 119:488\u2013493","journal-title":"Blood"},{"key":"7124_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00294378","volume":"79","author":"C Sommer","year":"1989","unstructured":"Sommer C, Schr\u00f6der JM (1989) Amyloid neuropathy: immunocytochemical localization of intra- and extracellular immunoglobulin light chains. Acta Neuropathol 79:190\u2013199","journal-title":"Acta Neuropathol"},{"key":"7124_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.proghi.2012.03.001","volume":"47","author":"RP Linke","year":"2012","unstructured":"Linke RP (2012) On typing amyloidosis using immunohistochemistry. Detailed illustrations, review and a note on mass spectrometry. Prog Histochem Cytochem 47:61\u2013132","journal-title":"Prog Histochem Cytochem"},{"key":"7124_CR5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/iub.340","volume":"62","author":"MA Liz","year":"2010","unstructured":"Liz MA, Mar FM, Franquinho F, Sousa MM (2010) Aboard transthyretin: from transport to cleavage. IUBMB Life 62:429\u2013435","journal-title":"IUBMB Life"},{"key":"7124_CR6","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1073\/pnas.75.9.4499","volume":"75","author":"PP Costa","year":"1978","unstructured":"Costa PP, Figueira AS, Bravo FR (1978) Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 75:4499\u20134503","journal-title":"Proc Natl Acad Sci USA"},{"key":"7124_CR7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jmbi.2002.5441","volume":"317","author":"I Cardoso","year":"2002","unstructured":"Cardoso I, Goldsbury CS, M\u00fcller SA et al (2002) Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J Mol Biol 317:683\u2013695","journal-title":"J Mol Biol"},{"key":"7124_CR8","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","volume":"276","author":"A Quintas","year":"2001","unstructured":"Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RMM (2001) Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 276:27207\u201327213","journal-title":"J Biol Chem"},{"key":"7124_CR9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10:1086\u20131097","journal-title":"Lancet Neurol"},{"key":"7124_CR10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.20644","volume":"35","author":"I Concei\u00e7ao","year":"2007","unstructured":"Concei\u00e7ao I, De Carvalho M (2007) Clinical variability in type I familial amyloid polyneuropathy (Val30\u00a0Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 35:116\u2013118","journal-title":"Muscle Nerve"},{"key":"7124_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1212\/WNL.56.4.431","volume":"56","author":"E Hund","year":"2001","unstructured":"Hund E, Linke RP, Willig F, Grau A (2001) Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology 56:431\u2013435","journal-title":"Neurology"},{"key":"7124_CR12","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Sletten K, Johansson B, Cornwell GG (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843\u20132845","journal-title":"Proc Natl Acad Sci USA"},{"key":"7124_CR13","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, DeVit M et al (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci USA 109:9629\u20139634","journal-title":"Proc Natl Acad Sci USA"},{"key":"7124_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/13506129.2010.483119","volume":"17","author":"T Coelho","year":"2010","unstructured":"Coelho T, Maia L, da Martins Silva A (2010) Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin familial amyloid polyneuropathy. Amyloid 17:75\u201376","journal-title":"Amyloid"},{"key":"7124_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd3675","volume":"11","author":"G Said","year":"2012","unstructured":"Said G, Grippon S, Kirkpatrick P (2012) Tafamidis. Nat Rev Drug Discov 11:185\u2013186","journal-title":"Nat Rev Drug Discov"},{"key":"7124_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1399-0004.1991.tb03085.x","volume":"40","author":"G Holmgren","year":"1991","unstructured":"Holmgren G, Steen L, Ekstedt J et al (1991) Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 40:242\u2013246","journal-title":"Clin Genet"},{"key":"7124_CR17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","volume":"341","author":"G Holmgren","year":"1993","unstructured":"Holmgren G, Steen L, Suhr O et al (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341:1113\u20131116","journal-title":"Lancet"},{"key":"7124_CR18","first-page":"3","volume-title":"Histological and histochemical stains and reactions. Muscle biopsy a practical approach","author":"V Dubowitz","year":"2007","unstructured":"Dubowitz V, Sewry C (2007) Histological and histochemical stains and reactions. Muscle biopsy a practical approach. Elsevier, Philadelphia, pp 3\u201339"},{"key":"7124_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00313906","volume":"232","author":"JM Schr\u00f6der","year":"1985","unstructured":"Schr\u00f6der JM, Hoheneck M, Weis J, Deist H (1985) Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol 232:83\u201390","journal-title":"J Neurol"},{"key":"7124_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5414\/NP300468","volume":"31","author":"J Weis","year":"2012","unstructured":"Weis J, Brandner S, Lammens M, Sommer C, Vallat J-M (2012) Processing of nerve biopsies: a practical guide for neuropathologists. Clin Neuropathol 31:7\u201323","journal-title":"Clin Neuropathol"},{"key":"7124_CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","volume":"36","author":"MD Benson","year":"2007","unstructured":"Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411\u2013423","journal-title":"Muscle Nerve"},{"key":"7124_CR22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","volume":"336","author":"DR Jacobson","year":"1997","unstructured":"Jacobson DR, Pastore RD, Yaghoubian R et al (1997) Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 336:466\u2013473","journal-title":"N Engl J Med"},{"key":"7124_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.22229","volume":"45","author":"S Mathis","year":"2012","unstructured":"Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM (2012) Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 45:26\u201331","journal-title":"Muscle Nerve"},{"key":"7124_CR24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1529-8027.2011.00331.x","volume":"16","author":"M Cappellari","year":"2011","unstructured":"Cappellari M, Cavallaro T, Ferrarini M et al (2011) Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Syst 16:119\u2013129","journal-title":"J Peripher Nerv Syst"},{"key":"7124_CR25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jmb.2008.07.029","volume":"382","author":"SK Palaninathan","year":"2008","unstructured":"Palaninathan SK, Mohamedmohaideen NN, Snee WC, Kelly JW, Sacchettini JC (2008) Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. J Mol Biol 382:1157\u20131167","journal-title":"J Mol Biol"},{"key":"7124_CR26","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.1021\/bi700607z","volume":"46","author":"LE Wilkinson-White","year":"2007","unstructured":"Wilkinson-White LE, Easterbrook-Smith SB (2007) Characterization of the binding of Cu(II) and Zn(II) to transthyretin: effects on amyloid formation. Biochemistry 46:9123\u20139132","journal-title":"Biochemistry"},{"key":"7124_CR27","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1021\/bi050378f","volume":"44","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Kelly JW (2005) Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S\/V30M transgenic mice? Biochemistry 44:9079\u20139085","journal-title":"Biochemistry"},{"key":"7124_CR28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1006\/bbrc.2000.2554","volume":"270","author":"MR Almeida","year":"2000","unstructured":"Almeida MR, Alves IL, Terazaki H, Ando Y, Saraiva MJ (2000) Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119\u00a0M. Biochem Biophys Res Commun 270:1024\u20131028","journal-title":"Biochem Biophys Res Commun"},{"key":"7124_CR29","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","volume":"99","author":"P Hammarstr\u00f6m","year":"2002","unstructured":"Hammarstr\u00f6m P, Jiang X, Hurshman Babbes AR, Powers ET, Kelly JW (2002) Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci USA 99:16427\u201316432","journal-title":"Proc Natl Acad Sci USA"},{"key":"7124_CR30","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","volume":"47","author":"AR Hurshman Babbes","year":"2008","unstructured":"Hurshman Babbes AR, Powers ET, Kelly JW (2008) Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis. Biochemistry 47:6969\u20136984","journal-title":"Biochemistry"},{"key":"7124_CR31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/hmg\/ddi051","volume":"14","author":"ML Soares","year":"2005","unstructured":"Soares ML, Coelho T, Sousa A et al (2005) Susceptibility and modifier genes in Portuguese transthyretin V30\u00a0M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet 14:543\u2013553","journal-title":"Hum Mol Genet"},{"key":"7124_CR32","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","volume":"21","author":"MM Sousa","year":"2001","unstructured":"Sousa MM, Du Y, Fernandes R, Guimar\u00e3es A, Stern D, Saraiva MJ (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21:7576\u20137586","journal-title":"J Neurosci"},{"key":"7124_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pneurobio.2003.11.002","volume":"71","author":"MM Sousa","year":"2003","unstructured":"Sousa MM, Saraiva MJ (2003) Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 71:385\u2013400","journal-title":"Prog Neurobiol"},{"key":"7124_CR34","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","volume":"59","author":"H Koike","year":"2002","unstructured":"Koike H (2002) Type I (transthyretin met30) familial amyloid polyneuropathy in japan: early- vs late-onset form. Arch Neurol 59:1771\u20131776","journal-title":"Arch Neurol"},{"key":"7124_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/13506129.2012.674580","volume":"19","author":"H Koike","year":"2012","unstructured":"Koike H, Sobue G (2012) Late-onset familial amyloid polyneuropathy in Japan. Amyloid 19:55\u201357","journal-title":"Amyloid"},{"key":"7124_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","volume":"63","author":"H Koike","year":"2004","unstructured":"Koike H, Misu K, Sugiura M et al (2004) Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63:129\u2013138","journal-title":"Neurology"},{"key":"7124_CR37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2009.07.028","volume":"287","author":"H Koike","year":"2009","unstructured":"Koike H, Ando Y, Ueda M et al (2009) Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 287:178\u2013184","journal-title":"J Neurol Sci"},{"key":"7124_CR38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1471-4159.2006.03716.x","volume":"97","author":"FA Monteiro","year":"2006","unstructured":"Monteiro FA, Sousa MM, Cardoso I, do Amaral JB, Guimar\u00e3es A, Saraiva MJ (2006) Activation of ERK1\/2 MAP kinases in familial amyloidotic polyneuropathy. J Neurochem 97:151\u2013161","journal-title":"J Neurochem"},{"key":"7124_CR39","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/j.febslet.2006.05.020","volume":"580","author":"FA Monteiro","year":"2006","unstructured":"Monteiro FA, Cardoso I, Sousa MM, Saraiva MJ (2006) In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE). FEBS Lett 580:3451\u20133456","journal-title":"FEBS Lett"},{"key":"7124_CR40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/labinvest.3780116","volume":"80","author":"MM Sousa","year":"2000","unstructured":"Sousa MM, Yan SD, Stern D, Saraiva MJ (2000) Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest 80:1101\u20131110","journal-title":"Lab Invest"},{"key":"7124_CR41","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","volume":"161","author":"MM Sousa","year":"2002","unstructured":"Sousa MM, Fernandes R, Palha JA, Taboada A, Vieira P, Saraiva MJ (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am J Pathol 161:1935\u20131948","journal-title":"Am J Pathol"},{"key":"7124_CR42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0169-409X(02)00160-6","volume":"54","author":"D Stern","year":"2002","unstructured":"Stern D, Du Yan S, Fang Yan S, Marie Schmidt A (2002) Receptor for advanced glycation end products: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615\u20131625","journal-title":"Adv Drug Deliv Rev"},{"key":"7124_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1529-8027.2008.00170.x","volume":"13","author":"M Kodaira","year":"2008","unstructured":"Kodaira M, Sekijima Y, Tojo K et al (2008) Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome. J Peripher Nerv Syst 13:148\u2013150","journal-title":"J Peripher Nerv Syst"},{"key":"7124_CR44","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2005-10-4148","volume":"107","author":"RL Comenzo","year":"2006","unstructured":"Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J (2006) Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood 107:3489\u20133491","journal-title":"Blood"},{"key":"7124_CR45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/13506129.2012.673139","volume":"19","author":"OB Suhr","year":"2012","unstructured":"Suhr OB, Ericzon B-G (2012) Selection of hereditary transthyretin amyloid patients for liver transplantation: the Swedish experience. Amyloid 19:78\u201380","journal-title":"Amyloid"},{"key":"7124_CR46","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00415-008-0962-z","volume":"255","author":"H Koike","year":"2008","unstructured":"Koike H, Kawagashira Y, Iijima M et al (2008) Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 255:1526\u20131533","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7124-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7124-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7124-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T12:45:21Z","timestamp":1716036321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7124-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["7124"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7124-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}